Zhejiang, China

Yingbin Huang

This inventor holds 1 USPTO granted patent. Top assignee: Ningbo Health Gene Technologies Co., Ltd.. Active years: 2018.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yingbin Huang: Innovator in Genetic Assessment Technologies

Introduction

Yingbin Huang is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of genetic assessment through his innovative methods and compositions. His work focuses on the detection and analysis of target polynucleotides, which are crucial in various medical applications.

Latest Patents

Yingbin Huang holds a patent for "Methods and compositions for assessing copy number of target polynucleotides." This invention relates to techniques for evaluating the copy number of a target polynucleotide in a sample. It also includes methods for establishing a standard curve for the target polynucleotide and applications for detecting pathogens, such as human papillomavirus (HPV). This patent highlights his expertise in molecular biology and its practical applications in healthcare.

Career Highlights

Huang is associated with Ningbo Health Gene Technologies Co., Ltd., where he applies his knowledge and skills to advance genetic research and technology. His work at this company emphasizes the importance of innovative solutions in the health sector, particularly in genetic diagnostics.

Collaborations

Some of his notable coworkers include Yong Wu and Tingting Sun. Their collaboration contributes to the development of cutting-edge technologies in the field of genetics.

Conclusion

Yingbin Huang's contributions to genetic assessment technologies demonstrate his commitment to innovation in healthcare. His patent and work at Ningbo Health Gene Technologies Co., Ltd. reflect the importance of advancements in genetic diagnostics.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…